Literature DB >> 2363051

Human CD4 binds immunoglobulins.

P Lenert1, D Kroon, H Spiegelberg, E S Golub, M Zanetti.   

Abstract

T cell glycoprotein CD4 binds to class II major histocompatibility molecules and to the human immunodeficiency virus (HIV) envelope protein gp120. Recombinant CD4 (rCD4) bound to polyclonal immunoglobulin (Ig) and 39 of 50 (78%) human myeloma proteins. This binding depended on the Fab and not the Fc portion of Ig and was independent of the light chain. Soluble rCD4, HIV gp120, and sulfated dextrans inhibited the CD4-Ig interaction. With the use of a panel of synthetic peptides, the region critical for binding to Ig was localized to amino acids 21 to 38 of the first extracellular domain of CD4. CD4-bound antibody (Ab) complexed with antigen approximately 100 times better than Ab alone. This activity may contribute to the Ab-mediated enhancement of cellular HIV interaction that appears to depend on a trimolecular complex of HIV, antibodies to gp120, and CD4.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2363051     DOI: 10.1126/science.2363051

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

1.  An Fc receptor for human immunoglobulin G is located within the tegument of human cytomegalovirus.

Authors:  L M Stannard; D R Hardie
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

2.  Novel unconventional binding site in the variable region of immunoglobulins.

Authors:  K Rajagopalan; G Pavlinkova; S Levy; P R Pokkuluri; M Schiffer; B E Haley; H Kohler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 3.  The biology and pathology of Fc receptors.

Authors:  M Sandor; R G Lynch
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

Review 4.  Revenge of the microbes. Superantigens of the T and B cell lineage.

Authors:  L Goodglick; J Braun
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

5.  Differential effect on TCR:CD3 stimulation of a 90-kD glycoprotein (gp90/Mac-2BP), a member of the scavenger receptor cysteine-rich domain protein family.

Authors:  B Silvestri; F Calderazzo; V Coppola; A Rosato; S Iacobelli; C Natoli; A Ullrich; I Sures; M Azam; C Brakebush; L Chieco-Bianchi; A Amadori
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

6.  Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent.

Authors:  C A Jordan; B A Watkins; C Kufta; M Dubois-Dalcq
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

7.  Identification and characterization of an immunogenic hybrid epitope formed by both HIV gp120 and human CD4 proteins.

Authors:  George K Lewis; Timothy R Fouts; Sani Ibrahim; Brian M Taylor; Rachita Salkar; Yongjun Guan; Roberta Kamin-Lewis; James E Robinson; Anthony L Devico
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

8.  Active immunity against the CD4 receptor by using an antibody antigenized with residues 41-55 of the first extracellular domain.

Authors:  P Lanza; R Billetta; S Antonenko; M Zanetti
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

9.  Antigenized antibodies expressing Vbeta8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis.

Authors:  Cristina Musselli; Svetlana Daverio-Zanetti; Maurizio Zanetti
Journal:  J Immune Based Ther Vaccines       Date:  2004-11-12

Review 10.  Human immunodeficiency virus type 1-associated CD4 downmodulation.

Authors:  R Geleziunas; S Bour; M A Wainberg
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.